Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong.

Authors:
Cheung YYH; Lau EHY; Yin G; Lin Y; Cowling BJ and 1 more

Journal:
Emerg Infect Dis

Publication Year: 2023

DOI:
10.3201/eid3001.230414

PMCID:
PMC10756371

PMID:
38040664

Journal Information

Full Title: Emerg Infect Dis

Abbreviation: Emerg Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"all computer code related to this article has been made publicly available at the open science framework ( https://doi org/10 17605/osf io/2dr6m )."

Code Sharing
Evidence found in paper:

"B.J.C. consults for AstraZeneca, Fosun Pharma, GlaxoSmithKline, Haleon, Moderna, Pfizer, Roche, and Sanofi Pasteur. The other authors report no other potential conflicts of interest."

Evidence found in paper:

"This project was supported by the Health and Medical Research Fund of the Health Bureau, Government of the Hong Kong Special Administrative Region, China (grant no. CID-HKU2-12). The funding bodies had no role in the design of the study; collection, analysis, and interpretation of data; or writing of the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025